FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 546 · page 5 of 25 of this heading
DIABETES MELLITUS TYPE I OR TYPE II - INSULIN TREATED CGM OPTION
C. CERTIFICATION AID
(Updated 09/30/2026)
The following are the specifics of the ITEM numbers listed in the Initial and Renewal
requirements:
ITEM #1: INITIAL COMPREHENSIVE REPORT (Updated 03/30/2022)
INITIAL COMPREHENSIVE in-person evaluation performed within the past 90 days from the treating
board-certified endocrinologist. The individual must submit a copy of the actual comprehensive current,
detailed Clinical Progress Note. (We will NOT accept the patient encounter summary or a letter from
*1
the endocrinologist.) It must detail and comment on ALL of the following :
A. DIABETES HISTORY:
1. Characteristics at onset (age, symptoms, etc.):
a) Review previous treatment and response
b) Frequency/cause/severity of past hospitalizations
c) Complications and common comorbidities:
• Any end organ damage (macrovascular or microvascular);
• Presence of hemoglobinopathies or anemias;
• High blood pressure or abnormal lipids and treatment; and
• Visits to specialist (what type and why)
d) Lifestyle and behavior patterns:
• Eating patterns and weight history;
• Sleep behavior and physical activity;
• Familiarity with carbohydrate counting, if applicable;
• Tobacco, alcohol, and substance use; and
• Any motor vehicle accidents or incidents pertinent to their history of diabetes
2. Medication and Reporting:
a) Medication compliance;
b) Medication intolerance or side effects;
c) Complementary or alternative medicine use;
d) Glucose monitoring (meter/CGM) results and data use; and
e) Review insulin pump settings
3. Screening for Psychosocial conditions:
a) Screen for depression, anxiety, disordered eating (ex: Patient Health Questionnaire 9 or 2
[PHQ-9 or PHQ-2] or similar);
b) Cognitive impairment assessment (and formal testing, if clinically indicated); and
c) Diabetes self-management education and support:
• History of dietician/diabetes educator visits; and
• Screen for barriers to diabetes self-management
4. Glucose control:
a) HYPOglycemia:
• Any symptomatic episodes in the past 12 months requiring treatment or
assistance by another individual, with comment on timing, awareness, frequency,
causes, and treatment.
• Sustained episodes, e.g., CGM/FSBG values below 70 mg/dL for over 30 minutes
or below 54 mg/dL for over 15 minutes, with comment on symptoms and
treatment.
b) HYPERglycemia:
• Any symptomatic episodes in the past 12 months with comment on timing,
awareness, frequency, causes, and treatment.
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
What else should I look at?
Navigation aids drawn from the Guide's own structure and explicit cross-references. They are not medical or certification decisions.
FAA Guide for Aviation Medical Examiners, Version 10/28/2026. AME Copilot is an independent reference tool, not affiliated with or endorsed by the FAA. The FAA AME Guide is the authoritative source. Types such as “Protocol” are reading aids; AME Copilot does not make certification decisions.